Blueberries Medical Corp.
BBRRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $36 | $58 | $55 | $265 |
| % Growth | -38.5% | 4.8% | -79.2% | – |
| Cost of Goods Sold | $11 | $32 | $34 | $184 |
| Gross Profit | $25 | $25 | $22 | $81 |
| % Margin | 69.3% | 44% | 39.3% | 30.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $196 | $191 | $754 | $213 |
| SG&A Expenses | $196 | $191 | $754 | $213 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $29 | $31 | $32 | $54 |
| Operating Expenses | $224 | $222 | $786 | $267 |
| Operating Income | -$200 | -$196 | -$764 | -$186 |
| % Margin | -560.4% | -339.1% | -1,383.4% | -70.1% |
| Other Income/Exp. Net | $10 | -$6 | -$13 | -$200 |
| Pre-Tax Income | -$189 | -$202 | -$776 | -$386 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$136 | -$202 | -$776 | -$386 |
| % Margin | -381.2% | -349.2% | -1,406.1% | -145.6% |
| EPS | 0 | -0 | -0.002 | -0.001 |
| % Growth | 100% | 78.9% | -90% | – |
| EPS Diluted | 0 | -0 | -0.002 | -0.001 |
| Weighted Avg Shares Out | 495,090 | 495,090 | 405,429 | 399,025 |
| Weighted Avg Shares Out Dil | 495,090 | 495,090 | 405,429 | 399,025 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $24 | $24 | $26 | $27 |
| EBITDA | -$165 | -$178 | -$738 | -$359 |
| % Margin | -462.9% | -307.2% | -1,336.3% | -135.3% |